Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 93 matching records.
93 results — page 1 of 4
- Level BClinical TrialEurope PMC
Stem cell therapy for female stress urinary incontinence: Results, limitations and lessons learned from a pilot clinical study
Clinical Trial, published in PLoS One (2026) — summary generated from the PubMed abstract.
- 2026
PLoS One1 citations - Level DLaboratory StudyPubMed
Research Trends in Stem Cell Therapy for Stress Urinary Incontinence from 2000 to 2025: A Bibliometric Analysis.
Laboratory Study, published in Curr Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Curr Stem Cell Res Ther - Level DNarrative ReviewEurope PMC
Regenerative Medicine Approaches to Stress Urinary Incontinence
Narrative Review on Face & Skin, published in Biomimetics (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Biomimetics (Basel) - Level AMeta-analysisEurope PMC
Autologous regenerative cell therapy for female stress urinary incontinence: a systematic review and meta-analysis of clinical outcomes
Meta-analysis with a reported sample of 591, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 591
Front Med (Lausanne) - Level DAnimal StudyPubMed
The Nerve-Induced Adipose Stem Cells Promote Nerve Repair in Stress Urinary Incontinence by Regulating Schwann Cell Repair Phenotype Conversion Through Activation of the Notch Pathway.
Animal Study, published in Mol Neurobiol (2025) — summary generated from the PubMed abstract.
- 2025
Mol Neurobiol3 citations - Level DNarrative ReviewEurope PMC
Progress of mesenchymal stem cells affecting extracellular matrix metabolism in the treatment of female stress urinary incontinence
Narrative Review, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther4 citations - Level DNarrative ReviewEurope PMC
Exosome Therapy in Stress Urinary Incontinence: A Comprehensive Literature Review
Narrative Review on Chronic Inflammation, published in Biomedicines (2025) — summary generated from the PubMed abstract.
- 2025
Biomedicines2 citations - Level ASystematic ReviewEurope PMC
Modern Conservative Management Strategies for Female Stress Urinary Incontinence: A Systematic Review
Systematic Review, published in J Clin Med (2025) — summary generated from the PubMed abstract.
- 2025
J Clin Med4 citations - Level BClinical TrialEurope PMC
Critical Appraisal of Evidence on Platelet-Rich Plasma and Stem Cell Therapy for Stress Urinary Incontinence: A Narrative Review
Clinical Trial, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus - Level DNarrative ReviewPubMed
Candidate Scaffolds for the Treatment of Stress Urinary Incontinence: A Narrative Review.
Narrative Review on Chronic Inflammation, published in Neurourol Urodyn (2025) — summary generated from the PubMed abstract.
- 2025
Neurourol Urodyn - Level DAnimal StudyPubMed
Adipose-derived stem cell exosomes for stress urinary incontinence: a novel in vivo therapeutic approach.
Animal Study on Systemic / IV, published in Int Urol Nephrol (2025) — summary generated from the PubMed abstract.
- 2025
Int Urol Nephrol1 citations - Level DAnimal StudyPubMed
Myogenic induced adipose-derived stem cells sheets combined with electrospun scaffolds of silk fibroin and poly(lactide-co-glycolide) for stress urinary incontinence treatment.
Animal Study, published in J Mol Histol (2025) — summary generated from the PubMed abstract.
- 2025
J Mol Histol - Level DAnimal StudyPubMed
Injectable therapeutic system incorporating neurogenesis-programmed stem cells concomitantly promoting muscle regeneration treats stress urinary incontinence.
Animal Study, published in Nat Commun (2025) — summary generated from the PubMed abstract.
- 2025
Nat Commun - Level DNarrative ReviewEurope PMC
Stem cell-based regeneration therapies in stress urinary incontinence: Mechanisms, innovation, and challenges
Narrative Review, published in Cell Transplant (2025) — summary generated from the PubMed abstract.
- 2025
Cell Transplant1 citations - Level BClinical TrialEurope PMC
Cell Therapy in the Treatment of Female Stress Urinary Incontinence: Current Status and Future Proposals
Clinical Trial, published in Life (Basel) (2024) — summary generated from the PubMed abstract.
- 2024
Life (Basel)1 citations - Level DNarrative ReviewPubMed
Animal models, treatment options, and biomaterials for female stress urinary incontinence.
Narrative Review, published in Front Bioeng Biotechnol (2024) — summary generated from the PubMed abstract.
- 2024
Front Bioeng Biotechnol5 citations - Level BClinical TrialEurope PMC
Microenergy shockwave therapies for female stress urinary incontinence
Clinical Trial, published in Transl Androl Urol (2024) — summary generated from the PubMed abstract.
- 2024
Transl Androl Urol1 citations - Level ASystematic ReviewEurope PMC
Cellular regenerative therapy in stress urinary incontinence: new frontiers?-a narrative review
Systematic Review, published in Transl Androl Urol (2024) — summary generated from the PubMed abstract.
- 2024
Transl Androl Urol5 citations - Level CProspective StudyPubMed
Stem Cell Application for Stress Urinary Incontinence: From Bench to Bedside.
Prospective Study, published in Curr Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Curr Stem Cell Res Ther3 citations - Level AMeta-analysisPubMed
Regenerative Medicine-Based Treatment of Stress Urinary Incontinence with Mesenchymal Stem Cells: A Systematic Review and Meta-analysis.
Meta-analysis with a reported sample of 123, published in Curr Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
- n = 123
Curr Stem Cell Res Ther - Level BClinical TrialEurope PMC
Mesenchymal stem cell-based therapy for female stress urinary incontinence
Clinical Trial, published in Front Cell Dev Biol (2023) — summary generated from the PubMed abstract.
- 2023
Front Cell Dev Biol6 citations - Level DNarrative ReviewEurope PMC
Advances in the molecular pathogenesis and cell therapy of stress urinary incontinence
Narrative Review, published in Front Cell Dev Biol (2023) — summary generated from the PubMed abstract.
- 2023
Front Cell Dev Biol16 citations - Level CRetrospective StudyEurope PMC
Comparison of urethral sling surgery and non-ablative vaginal Erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis
Retrospective Study with a reported sample of 327, published in Lasers Med Sci (2022) — summary generated from the PubMed abstract.
- 2022
- n = 327
Lasers Med Sci19 citations - Level DAnimal StudyEurope PMC
Urethral injection of dedifferentiated fat cells ameliorates sphincter damage and voiding dysfunction in a rat model of persistence stress urinary incontinence
Animal Study, published in Int Urol Nephrol (2022) — summary generated from the PubMed abstract.
- 2022
Int Urol Nephrol4 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406